HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Vytautas Smirnovas Selected Research

Neurodegenerative Diseases (Neurodegenerative Disease)

9/2021Using lysozyme amyloid fibrils as a means of scavenging aggregation-inhibiting compounds.
8/2021Co-Aggregation of S100A9 with DOPA and Cyclen-Based Compounds Manifested in Amyloid Fibril Thickening without Altering Rates of Self-Assembly.
6/2021Polyoxometalates as Effective Nano-inhibitors of Amyloid Aggregation of Pro-inflammatory S100A9 Protein Involved in Neurodegenerative Diseases.
1/2021Exploring the occurrence of thioflavin-T-positive insulin amyloid aggregation intermediates.
12/2020Identifying Insulin Fibril Conformational Differences by Thioflavin-T Binding Characteristics.
12/2020Formation of distinct prion protein amyloid fibrils under identical experimental conditions.
11/2020Effect of Ionic Strength on Thioflavin-T Affinity to Amyloid Fibrils and Its Fluorescence Intensity.
10/2020Self-Replication of Prion Protein Fragment 89-230 Amyloid Fibrils Accelerated by Prion Protein Fragment 107-143 Aggregates.
1/2020Methylene blue inhibits nucleation and elongation of SOD1 amyloid fibrils.
1/2020Gallic acid oxidation products alter the formation pathway of insulin amyloid fibrils.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Vytautas Smirnovas Research Topics

Disease

15Neurodegenerative Diseases (Neurodegenerative Disease)
09/2021 - 01/2019
11Parkinson Disease (Parkinson's Disease)
06/2022 - 01/2019
8Amyloidosis
05/2022 - 11/2018
4Prion Diseases (Transmissible Spongiform Encephalopathies)
09/2021 - 09/2009
2Inflammation (Inflammations)
07/2021 - 06/2020
2Alzheimer Disease (Alzheimer's Disease)
01/2021 - 06/2020
2Neoplasms (Cancer)
04/2017 - 11/2014
1Amyloid Plaque
07/2021
1Neuroblastoma
01/2021
1Creutzfeldt-Jakob Syndrome (Creutzfeldt-Jakob Disease)
12/2020
1Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
01/2020
1Phenylketonurias (Phenylketonuria)
01/2019
1Neuroinflammatory Diseases
01/2019
1Scrapie
09/2009
1Diabetes Mellitus
06/2008
1Insulin Resistance
06/2008
1Insulinoma
07/2007

Drug/Important Bio-Agent (IBA)

19Amyloid (Amyloid Fibrils)IBA
06/2022 - 06/2008
10Proteins (Proteins, Gene)FDA Link
07/2021 - 11/2018
7Amyloidogenic ProteinsIBA
01/2022 - 10/2019
4Prion ProteinsIBA
09/2021 - 09/2009
3Calgranulin BIBA
06/2021 - 01/2019
3Insulin (Novolin)FDA Link
12/2019 - 07/2007
2alpha-SynucleinIBA
06/2022 - 07/2021
1Protein AggregatesIBA
11/2021
1PrionsIBA
09/2021
1CalciumIBA
07/2021
1Olive OilIBA
01/2021
1oleuropein aglyconeIBA
01/2021
1PolyphenolsIBA
01/2021
1Peptides (Polypeptides)IBA
06/2020
1Superoxide DismutaseIBA
01/2020
1Gallic AcidIBA
01/2020
1epigallocatechin gallate (epigallocatechin-3-gallate)IBA
12/2019
1SolutionsIBA
12/2019
1SynucleinsIBA
12/2019
1Phenylalanine (L-Phenylalanine)FDA Link
01/2019
1Protein Isoforms (Isoforms)IBA
04/2017
1Carbonic Anhydrase IXIBA
11/2014
1HydrogenIBA
09/2009
1DeuteriumIBA
09/2009
1Peptide Hydrolases (Proteases)FDA Link
09/2009

Therapy/Procedure

1Mediterranean Diet
01/2021